AnaptysBio’s Spinoff Is Done. Is ANAB or TRAX the Better Bet?
AnaptysBio(ANAB) completed the spinoff of First Tracks Biotherapeutics (TRAX) on April 20. We wrote about the planned separation back in October, when the announcement sent AnaptysBio shares up more than 30%. Then the spinoff happened, First Tracks started trading, and we haven’t gotten around to discussing it now. Hopefully, we will have a lot of late posts coming… Read More »